| Glaucoma Physician
Inder Paul Singh, MD, and Nathan Radcliffe, MD, discuss the benefits of early treatment.
Inder Paul Singh, MD, and Nathan Radcliffe, MD, discuss the benefits of early treatment.
A 71-year-old woman had 2 months of worsening vision and pain in her right eye. Examination revealed retrocorneal plaque, peaking of the pupil, and temporal…
The trial is designed to enable a resubmission of a New Drug Application to the US FDA for reproxalap after receiving a Complete Response Letter…
Two randomized, double-masked, placebo-controlled, Phase 3 trials named REVEAL-1 and REVEAL-2 are expected to start in August 2024.
The trial is designed to enable a resubmission of a New Drug Application to the US FDA for reproxalap after receiving a Complete Response Letter…
The SARS-CoV-2 virus is found to cross the blood–retina barrier, taking daily low-dose aspirin may not be protective against developing AMD, and patients with multiple…
Over 380 organizations representing patients, health care providers, the medical technology and biopharmaceutical industry, health plans and others endorse the legislation
Overall, Axpaxli demonstrated promising safety and efficacy outcomes.
For Glaucoma Physician’s Surgical Pearls video series, Aaki Shukla, MD, and Ari Leshno, MD, demonstrate management of a case of a thin trabeculectomy flap. Transcript…